Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide

Bispebjerg Hospital

Status: Unknown

Conditions: Hypersensitivity, Immediate; Asthma, Bronchial; Allergic Rhinitis

Treatments: Biological: Specific immunotherapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00312312

SITNO

Details and patient eligibility

About

The purpose of this study is to evaluate the immunomodulatory effect of treatment of allergic rhinitis symptoms with specific immunotherapy by measurement of pulmonary inflammatory markers, and among others, exhaled nitric oxide.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18-45 years old
• Skin prick test or RAS test and physical examination conclude that the patient will have a beneficial effect from specific immunotherapy

Exclusion criteria

• Other diseases except atopic disease
• Pregnancy

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)